The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior - PubMed (original) (raw)
. 1993 Mar 15;53(6):1262-8.
Affiliations
- PMID: 8443806
The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior
W Rudy et al. Cancer Res. 1993.
Abstract
The metastatic pancreas carcinoma cell line BSp73ASML produces a variety of different splice variants of the transmembrane glycoprotein CD44. The NH2-terminal portions are identical and heavily glycosylated. The variant sequences are inserted just outside the transmembrane region of the molecules. The two most abundant variants have 162 and 85 extra amino acids, respectively. When individually expressed, these suffice to establish metastatic properties in the nonmetastatic tumor cell line BSp73AS, as assayed by the spontaneous metastasis protocol.
Similar articles
- A link between ras and metastatic behavior of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells.
Hofmann M, Rudy W, Günthert U, Zimmer SG, Zawadzki V, Zöller M, Lichtner RB, Herrlich P, Ponta H. Hofmann M, et al. Cancer Res. 1993 Apr 1;53(7):1516-21. Cancer Res. 1993. PMID: 8453616 - Hyaluronate-independent metastatic behavior of CD44 variant-expressing pancreatic carcinoma cells.
Sleeman JP, Arming S, Moll JF, Hekele A, Rudy W, Sherman LS, Kreil G, Ponta H, Herrlich P. Sleeman JP, et al. Cancer Res. 1996 Jul 1;56(13):3134-41. Cancer Res. 1996. PMID: 8674073 - CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines.
Hofmann M, Rudy W, Zöller M, Tölg C, Ponta H, Herrlich P, Günthert U. Hofmann M, et al. Cancer Res. 1991 Oct 1;51(19):5292-7. Cancer Res. 1991. PMID: 1717145 - CD44 splice variants: metastases meet lymphocytes.
Herrlich P, Zöller M, Pals ST, Ponta H. Herrlich P, et al. Immunol Today. 1993 Aug;14(8):395-9. doi: 10.1016/0167-5699(93)90141-7. Immunol Today. 1993. PMID: 7691067 Review. - The transmembrane hyaluronate receptor (CD44): multiple functions, multiple forms.
Haynes BF, Liao HX, Patton KL. Haynes BF, et al. Cancer Cells. 1991 Sep;3(9):347-50. Cancer Cells. 1991. PMID: 1721518 Review. No abstract available.
Cited by
- Splicing factor SRSF2-centric gene regulation.
Li K, Wang Z. Li K, et al. Int J Biol Sci. 2021 Apr 16;17(7):1708-1715. doi: 10.7150/ijbs.58888. eCollection 2021. Int J Biol Sci. 2021. PMID: 33994855 Free PMC article. Review. - Conditions of tumor-associated antigens as a proper target for therapeutic antibodies against solid cancers.
Kurosawa Y. Kurosawa Y. J Stem Cells Regen Med. 2011 Apr 1;7(1):14-28. doi: 10.46582/jsrm.0701003. eCollection 2011. J Stem Cells Regen Med. 2011. PMID: 24693169 Free PMC article. - Monoclonal antibodies to CD44 and their influence on hyaluronan recognition.
Zheng Z, Katoh S, He Q, Oritani K, Miyake K, Lesley J, Hyman R, Hamik A, Parkhouse RM, Farr AG, Kincade PW. Zheng Z, et al. J Cell Biol. 1995 Jul;130(2):485-95. doi: 10.1083/jcb.130.2.485. J Cell Biol. 1995. PMID: 7542251 Free PMC article. - Detection of high CD44 expression in oral cancers using the novel monoclonal antibody, C44Mab-5.
Yamada S, Itai S, Nakamura T, Yanaka M, Kaneko MK, Kato Y. Yamada S, et al. Biochem Biophys Rep. 2018 Apr 12;14:64-68. doi: 10.1016/j.bbrep.2018.03.007. eCollection 2018 Jul. Biochem Biophys Rep. 2018. PMID: 29872736 Free PMC article. - CD44 variant isoforms are preferentially expressed in basal epithelial of non-malignant human fetal and adult tissues.
Terpe HJ, Stark H, Prehm P, Günthert U. Terpe HJ, et al. Histochemistry. 1994 Feb;101(2):79-89. doi: 10.1007/BF00269353. Histochemistry. 1994. PMID: 7520892
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous